Skip to main content

Table 1 Association between NLR/PNI value and clinicopathological findings

From: Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer

  Number NLR PNI
All cases 334 2.52 ± 2.06 51.03 ± 5.72
 Age
70 165 2.34 ± 1.91 52.20 ± 5.38*
 >70 169 2.69 ± 2.18 49.59 ± 5.70*
Smoking history
 Never 122 2.27 ± 1.69 52.32 ± 5.00**, ***
 Former 116 2.69 ± 2.41 49.70 ± 5.65**
 Current 95 2.64 ± 1.99 50.97 ± 6.36***
Histology
 Adenocarcinoma 231 2.43 + 2.07 51.87 + 5.17****
 Squamous cell carcinoma 69 2.80 + 2.30 48.22 + 6.49****
 Large cell carcinoma 22 2.84 + 1.42 49.55 + 6.38
 Adenosquamous carcinoma 6 2.01 + 0.61 52.49 + 2.39
 Pleomorphic carcinoma 6 1.90 + 0.93 55.07 + 6.92
Tumor differentiation
 Well 118 2.39 + 2.12 51.82 + 4.70
 Moderate 115 2.55 + 2.29 50.96 + 6.12
 Poor 101 2.59 + 1.70 50.23 + 6.30
Pathological stage
 IA 144 2.40 + 2.13 51.74 + 5.33
 IB 95 2.54 + 1.68 50.30 + 6.00
 IIA+IIB 55 2.60 + 2.21 50.30 + 5.50
 IIIA+IIIB 40 2.75 + 2.37 51.18 + 6.58
  1. NLR neutrophil/lymphocyte ratio, PNI prognostic nutritional index
  2. *, **, ****p < 0.01
  3. ***p < 0.05